This Viewpoint clarifies 3 treatment options for treating patients with elevated cholesterol levels by discussing patient goals, encouraging lifestyle changes, and using lipid-lowering medication.
This Recommendation Statement from the US Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.
This 40-year observational study reports that sustained, community-wide programs targeting cardiovascular risk factors and behavior changes to improve a Maine county’s population health were associated with reductions in hospitalization and mortality.
This JAMA Clinical Evidence Synopsis discusses the association of fixed-dose combination therapy (polypill) and a reduced risk for cardiovascular disease (CVD).
You currently have no searches saved.